HPHanna C. Persson

Hanna C. Persson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hanna C. Persson has a total of 182 co-authors. Here are the top co-authors by number of shared publications:

  • Katharina Stibrant Sunnerhagen

    University of Gothenburg

    16 shared publications
  • Annie Palstam

    Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden

    5 shared publications
  • Emma Westerlind

    Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    5 shared publications
  • Karin Törnbom

    Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden; Department of Social Work, University of Gothenburg, Gothenburg, Sweden; Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    5 shared publications
  • Emma Westerlind

    Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, Gothenburg, Sweden

    4 shared publications
  • Alexandra C. Larsson

    Department of Clinical Neuroscience and Rehabilitation Medicine, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    3 shared publications

Latest Publications

  • Open Access

    Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database

    by Myzoon Ali, Marian C Brady, Pauline Campbell, Scott Rooney, Linda Williams, Lorna Paul, Helen Mason, Sarkis Manoukian, Charlie Chung, Mark Barber, et al.

    Background: Identifying and addressing long-term health and societal challenges after COVID-19 is a research priority. Objectives: To create an international, multidisciplinary COVID-19 database, and synthesise long-term outcomes, predictors and costs. Design: Systematic identification of COVID-19 data sets and meta-analysis of individual participant data on long-term outcomes after COVID-19. Setting: Contributed data were collected in clinical, community and research settings. Interventions: Interventions from original studies were included as covariates in models. Data sources: MEDLINE, Cochrane Central Register of Controlled Trials, EMBASE, Web of Science, PsycInfo ® (American Psychological Association, Washington, DC, USA), Cumulative Index to Nursing and Allied Health Literature, World Health Organization Global Index Medicus, Epistemonikos, LitCOVID; World Health Organization International Clinical Trials Registry Platform; ClinicalTrials.gov and supplementary searches for studies (November 2019–November 2021) were searched for studies on > 10 people from cohort, case-control, survey or randomised controlled trial studies, across any setting, describing validated assessment instruments, symptoms, hospitalisation, discharge destination or mortality beyond 28-days after COVID-19 onset. Data were extracted by two independent reviewers. Methods: Principal investigators contributed fully anonymised individual participant data. Demography, equity and symptoms were described. Assessment instruments were mapped to the International Classification of Functioning, Disability and Health. Factors associated with outcomes at 3–6 months, 9–12 months and beyond 12 months of index infection, for n > 500 individual participant data and > 1 data set were described using ratio of difference, point estimates, odds ratio and 95% confidence interval, as appropriate. The Mixed Methods Appraisal Tool described study quality; models were appraised using a Grading of Recommendations Assessment, Development and Evaluation-informed approach; heterogeneity was described using I 2 . Outcome measures: Included overall perception of health, multidomain cognitive function, anxiety, depression, stress, post-traumatic stress disorder, fatigue, strength, walking ability, mobility, coping with daily life, breathlessness, mortality, later hospitalisation and health-related quality of life. Results: PRECIOUS collated 116 data sets from 40 countries (individual participant data = 62,849), comprising 20 randomised controlled trials, 13 case-control, 60 cohort 2 longitudinal, 1 survey and 20 other study types. Participants’ median age was 58 years interquartile range (45–68); 34,185 (54.4%) were female; 158 unique symptoms and 137 unique assessment instruments were captured, predominantly describing International Classification of Function, Disability and Health-body functions. Women had poorer outcomes across 30/37 models, compared with men. In 15/37 models, pre-existing lung disease and increasing age were associated with poorer outcomes; hospitalisation, diabetes and chronic kidney disease were each associated with poorer outcomes in 8/37 models. Initial hospitalisation resulted in lower health-related quality of life that did not recover for up to 2 years after initial infection. Heterogeneity was low in 34/37 models; 22/37 models were of moderate and 11/37 were of low quality. Limitations: Use of secondary data limits available covariates, outcomes and time points to those included in primary data sets; evidence was primarily based on high-income countries. There was a lack of data on longer-term healthcare resource use to estimate the costs to the healthcare system. Conclusions: PRECIOUS contributes to the overall picture of long-term COVID-19 outcomes beyond the long-COVID condition and highlights poorer long-term outcomes in women and people with pre-existing comorbidities. Future work: Evidence gaps included healthcare resource use, isolation, loneliness, societal participation and return to work outcomes. Data are needed on the role of health inequity on long-term outcomes. Study registration: This study is registered as PROSPERO (CRD42020224323, IRAS ID: 293578). Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health and Social Care Delivery Research programme (NIHR award ref: NIHR132895) and is published in full in Health and Social Care Delivery Research ; Vol. 14, No. 29. See the NIHR Funding and Awards website for further award information.


  • Open Access

    Sensitivity of physiotherapy-based clinical tests in detecting change in gait and balance performance following a 50 mL CSF tap test in idiopathic normal pressure hydrocephalus

    by Kardelen Akar, Lena Kollén, Mats Tullberg, Hanna C. Persson

    Background: Cerebrospinal fluid tap test (CSF TT) is a key predictive method commonly used to identify candidates for shunt surgery in idiopathic Normal Pressure Hydrocephalus (iNPH), however, the sensitivity of this procedure is limited. The aim was to compare sensitivity of a broad set of physiotherapy-based clinical tests for assessing changes following CSF TT in a group of selected iNPH patients and to explore potential sex-based differences in the responses. Methods: Ninety-five selected iNPH patients (mean age 77, SD 6, 57% male), underwent CSF TT prior to shunt surgery. Clinical tests comprised different static balance tests in varying conditions including feet and heels apart and together; eyes open and closed; on floor and foam cushion, followed by gait and functional performance measures including 10-meter walk test (10MWT), 3-meter backward walking (3MBW), Timed-up and Go (TUG) and 6-minute walking test (6MWT). Duration in seconds (sec) and distance were noted. Assessments were conducted at set time points before and after the drainage procedure. Changes in performance were analyzed, and responses compared between sexes. Results: Significant increase was observed across most static balance tests except tandem eyes closed (EC) and one-legged stance tests. The largest enhancements were seen in the Romberg test (4.9 s), followed by foam cushion-eyes open (EO) tests (feet together: 3.9 s and heels together: 3.8 s), heels together-EC (3.8 s) and tandem-EO (3.1 s). Gait and functional tests significantly improved ( p < 0.001) and 3MBW showed the largest change, with a 32% reduction in sec and a 23% reduction in steps, followed by decrease in TUG sec (27%) and 10-MWT sec (21%), and 6MWT distance increase (25%). Males demonstrated significant increase in heels together-EO and feet together-EO duration which were not observed in females; after adjusting for baseline performances, no significant sex-related differences in responsiveness to CSF TT were found. Conclusions: Challenging comprehensive physiotherapy tests, including gait assessments in direction and capacity, such as 3MBW and 6MWT, together with postural control evaluations using foam cushion and tandem stance increases the sensitivity to change and are suggested to be used to detect functional changes after CSF TT in patients with iNPH. Trail registration: The project is registered in "FoU inSweden” (Research and Development in Sweden) ID: 285356.


  • Open Access

    6-minute walk test and the 3-metre backward walk test are sensitive to postoperative gait improvement in idiopathic normal pressure hydrocephalus

    by Johanna Andersson, Lena Kollen, Hanna C Persson, Mats Tullberg

    Background: Gait impairment is a core symptom in idiopathic normal pressure hydrocephalus (iNPH), but commonly used tests like the 10-metre walk test (10MWT) may underestimate postoperative improvements. We evaluated the 6-minute walk test (6MWT) and 3-metre backward walk test (3MBWT) as outcome measures compared with 10MWT and Timed Up and Go (TUG) and explored sex-related and age-related differences in shunt-operated patients with iNPH. Methods: A retrospective study of 291 shunted patients with iNPH (62.5% male; mean age 73.3±6.2 years) was conducted. Gait function was assessed preoperatively and at a median of 5.4 months postoperatively. Outcomes were analysed using linear regression, with age and sex as covariates; improvement was described as per cent change from baseline. Correlations between tests were assessed with Spearman coefficients. Results: Postoperative changes were observed for all gait measures: 3MBWT time (40% reduction (95% CI 36% to 44%)), 6MWT distance (32% increase (95% CI 23% to 43%)), TUG time (28% reduction (95% CI 24% to 32%)) and 10MWT time (19–23% reduction (95% CI 16% to 25%)) at maximal speed and self-selected speed. Women performed worse than men both before and after shunt insertion, but improvement did not differ by sex when adjusting for baseline performance. Each 5-year increase in age reduced gait improvement by 3–8% (p<0.05). Preoperatively, 6MWT correlated strongly with 10MWT (ρ=−0.81) and 3MBWT with TUG (ρ=0.75), while the correlation between 6MWT and 3MBWT was moderate (ρ=−0.58) (all p<0.001). Conclusions: The 3MBWT and 6MWT capture postoperative gait changes and may provide complementary information to conventional gait assessments in iNPH.

  • Open Access

    Self-reported health, persistent symptoms, and daily activities 2 years after hospitalization for COVID-19

    by Roda Alhasan, Lena Rafsten, Alexandra C. Larsson, Katharina S. Sunnerhagen, Hanna C. Persson

    Introduction: Since the onset of the COVID-19 pandemic, 775 million cases have been reported globally. While many individuals recover fully, a significant proportion develop persistent symptoms. Numerous studies have investigated the long-term symptoms of COVID-19; however, the full extent and impact of these symptoms remain inadequately understood. The aim of this study was to investigate the prevalence of self-reported persistent symptoms, focusing on respiratory symptoms and fatigue and the impact on functional status 2 years after hospitalization for COVID-19.Methods: This study is prospective and includes participants from a longitudinal multi-center cohort that follows patients previously hospitalized due to COVID-19 (n = 211). The current study encompasses the 2-year follow-up, using post-hospitalization questionnaire surveys. Analyzed data were collected before discharge and at the 2-year follow-up. Participants were grouped by age, sex and COVID-19 severity and group comparisons where conducted. Logistic regression analysis was used to study functional impairment.Results: Two years after hospital discharge due to COVID-19, 125 participants completed the 2-year follow-up. The mean age of participants was 66 years (SD 12.2), and 68% were male. The majority of participants reported present respiratory symptoms (n = 83, 69%) and fatigue (n = 98, 78%) at the 2-year follow-up. Persistent respiratory symptoms and fatigue impacted functional status substantially (p = p = 0.028, respectively). No significant differences were observed among groups depending on age, sex, or severity of COVID-19.Conclusion: For some individuals regardless of age, sex or COVID-19 severity, respiratory symptoms and fatigue may persist for up to 2 years following COVID-19. Hence, having available support from professionals knowledgeable about COVID-19 is imperative. Further research is important to unravel the mechanisms of long-term symptoms following COVID-19 and to develop effective therapeutic and rehabilitative interventions.


  • Open Access

    Self-reported body function and daily life activities 18 months after Covid-19: A nationwide cohort study

    by Johanna Seljelid, Annie Palstam, Katharina S. Sunnerhagen, Hanna C. Persson

    Aims: This study aimed to investigate body function and daily life activities 18 months after Covid-19 infection, depending on the initial severity of disease and according to sex. Methods: All 11,955 individuals on sick leave due to Covid-19 during the first wave of the pandemic in Sweden were invited to answer a questionnaire regarding experiencing negative changes in body function and daily life activities approximately 18 months after the start of sick leave. The analysis of data included descriptive statistics, group comparisons and multivariable binary logistic regressions (two groups). Results: Of 5464 responders (45.7%), 4676 (85.6%) reported experiencing at least one problem with body function, and the reported prevalence of problems with daily life activities was 46%. The most frequently reported problems were fatigue (66.3%), cognition, sleep and movement. In general, women and those initially hospitalised reported more problems. In the regression analyses, problems with body function could partly explain whether individuals experienced problems with daily life activities. However, only fatigue and movement significantly contributed throughout all groups ( p In this nationwide study, more than 8 out of 10 individuals experienced problems with body function 18 months after being on sick leave due to Covid-19, with women and those initially hospitalised reporting more problems. Problems with body function, such as fatigue, could partly explain problems with daily life activities. However, the mechanisms behind the consequences are not yet clear and need to be further investigated.


  • Open Access

    Variations in respiratory and functional symptoms at four months after hospitalisation due to COVID-19: a cross-sectional study

    by Monika Fagevik Olsén, Louise Lannefors, Ewa-Lena Johansson, Hanna C. Persson

    Background: Much remains unknown about complex respiratory symptoms after COVID-19. Here we aimed to describe and analyse patients’ various respiratory symptoms 4 months after discharge from hospitalisation for COVID-19, focusing on sex, previous pulmonary disease, and prolonged mechanical ventilation. Methods: This cross-sectional study involved five hospitals and included 52 patients with self-assessed respiratory dysfunction at 4 months after discharge from hospitalisation for severe COVID-19. Their average age was 63 years, 38% were women, 15 had a previous diagnosed pulmonary disease, and 29 were current or previous smokers. Additionally, 31 had required intensive care—among whom 21 were intubated and 11 needed mechanical ventilation for ≥20 days. Respiratory function was tested concerning lung volumes, expiratory flow, muscle strength, physical capacity (including concurrent oxygen saturation), thoracic expansion, and respiratory movements. Results: Among 52 patients, 47 (90%) had one or several objectively measured respiratory function abnormalities. Decreased thoracic expansion was observed in 32 patients (62%), abnormal respiratory movements in 30 (58%), decreased vital capacity in 21 (40%), low physical function in 13 (26%), and desaturation during the test in 9 (17%). Respiratory inspiratory muscle strength was more commonly diminished than expiratory strength (27% vs. 8%). We did not observe differences between men and women, or between patients with versus without diagnosed pulmonary disease, except that those with pulmonary disease had significantly lower physical capacity assessed with 6MWD (70% vs. 88% predicted, p = 0.013). Compared to those who did not, patients who required ≥20 days of mechanical ventilation performed similarly on most tests, except that all thoracic breathing movements were significantly smaller (p < 0.05). The numbers and combinations of abnormal findings varied widely, without clear patterns. Conclusion: Patients with remaining respiratory symptoms 4 months after discharge from hospitalization due to COVID-19 may suffer from various abnormal breathing functions, and dysfunctional breathing that is not detected using traditional measurements. These patients may benefit from multidimensional measuring of breathing movement, thoracic expansion, and respiratory muscle strength, along with traditional measurements, to assess their symptoms and enable prescription of optimal treatment interventions and rehabilitation. Trial registration: FoU i Sverige (Research & Development in Sweden, Registration number: 274476, registered 2020-05-28).


  • Open Access

    Figuring Out Life After Covid-19: a Qualitative Study From Sweden

    by Alexandra C. Larsson, Karin Törnbom, Katharina S. Sunnerhagen, Annie Palstam, Hanna C. Persson

    Objective: To obtain a deeper understanding of the daily life experiences of working aged people during the year following hospitalization due to SARS-CoV-2 (COVID-19), with a focus on function­ing in daily life and return to work. Design: An explorative qualitative study using individual interviews. Subjects: A purposive sample was selected of persons who had received inpatient hospital care, had been discharged approximately 1 year previously and were of working age. Methods: Semi-structured interviews were conducted with 11 participants (9 men, 2 women). The interviews were transcribed and analysed with inductive thematic analysis. Results: Four themes were identified. Navigating health, with or without support from healthcare, was described as challenging when managing consequences of COVID-19. Participants struggled with a lack of energy that interfered with daily life. It was a trial-and-error process trying to use familiar strategies in new ways to manage. The return to work process was facilitated by own strategies and support. Conclusion: This study contributes increased knowledge of everyday life experiences of people 1 year following hospitalization due to COVID-19. The lack of energy and a struggle to manage health while navigating the healthcare system emphasize the importance of strengthening personal and organizational health literacy to facilitate the recovery process after severe COVID-19.


  • Open Access

    Car accidents in drivers with Parkinson's disease or multiple sclerosis: A Swedish nationwide study

    by Linnea Anjemark, Helena Selander, Hanna C. Persson

    Background and purpose: Parkinson's disease (PD) and multiple sclerosis (MS) can impair driving. However, we lack evidence on car accidents associated with these diseases. The aims of this study were to examine what types of car accident were associated with drivers with PD and MS, compared to individuals with ulcerative colitis (UC; the comparison group), and to evaluate the occurrence of car accidents in relation to years since diagnosis.Methods: This retrospective nationwide, registry‐based study included drivers involved in car accidents between 2010 and 2019, based on the Swedish Traffic Accident Data Acquisition database. Data on pre‐existing diagnoses were retrieved retrospectively from the National Patient Registry. Data analyses included group comparisons, time‐to‐event analysis, and binary logistic regression.Results: In total, 1491 drivers, including 199 with PD, 385 with MS, and 907 with UC, were registered to have been involved in a car accident. The mean time from diagnosis to the car accident was 5.6 years for PD, 8.0 years for MS, and 9.4 years for UC. Time to car accident since diagnosis differed significantly (p < 0.001) among groups (adjusted for age). Drivers with PD had more than twice the odds of a single‐car accident than drivers with MS or UC, but no differences were observed between MS and UC.Conclusions: Drivers with PD were older and experienced the car accident within a shorter timeframe after disease diagnosis. Although several factors may cause a car accident, fitness to drive could be more thoroughly evaluated for patients with PD by physicians, even early after the diagnosis.


  • Open Access

    Back to life: Is it possible to be myself again? A qualitative study with persons initially hospitalised due to COVID-19

    by Karin Törnbom, Marie Engwall, Hanna C. Persson, Annie Palstam

    Objective: To gain a deeper understanding of the lived experiences of patients with COVID-19, regarding rehabilitation, work and social life 6 months after hospital discharge. Design: An explorative qualitative study with individual interviews. Subjects: Patients of working age with persistent self-reported symptoms at a 3-month follow-up who had received inpatient hospital care with discharge approximately 6 months previously were purposively sampled. Methods: Semi-structured interviews were performed with 10 men and 5 women. The interviews were transcribed verbatim and analysed with inductive thematic analysis. Results: Four themes were identified: “Social support – crucial, but decreased over time”, “Varying needs of, and access to, rehabilitation”, “Returning to work after COVID-19 – crucial for future prospects” and “An overwhelming experience that essentially changed one’s personality”. Conclusion: Rehabilitation provided participants with the valuable tools for recovery, giving them hope for future recovery. Support from next of kin was highly valued, creating stronger family bonds. A new meaning and greater appreciation of life was expressed.


  • Open Access

    Recovering from COVID-19 – A Process Characterised by Uncertainty: A Qualitative study

    by Marie Engwall, Karin Törnbom, Hanna C. Persson, Annie Palstam

    Objective: To obtain a deeper understanding of the lived experiences of patients with COVID-19, the recovery process and consequences for everyday life 6 months after hospital discharge.Design: An explorative qualitative study using individual interviews.Subjects: A purposive sampling was applied to recruit persons who had received inpatient hospital care, were discharged approximately 6 months previously, were of working age and had persistent self-reported symptoms at a 3-month follow-up appointment.Methods: Semi-structured interviews were conducted with 15 participants (10 men, 5 women), which were then transcribed and analysed with inductive thematic analysis.Results: Three themes were identified: “Status of recovery – two steps forward, one step back”, “Remaining symptoms caused limitations in everyday life” and “Strategies for recovery”. Participants indicated the recovery process through 6 months after discharge was a challenging road, often involving setbacks. A wide range of persistent, fluctuating, or new symptoms negatively impacted many areas of daily life, with fatigue and lack of energy being especially prominent. Participants used a variety of strategies to cope and recover.Conclusion: This study increases our knowledge of the lived experiences of COVID-19 based individual experiences. Unexpected symptoms in the recovery process were described and not always possible to forecast. LAY ABSTRACTThe aim of this study was to gain a deeper understanding of the lived experiences of patients with COVID-19, the recovery process and impacts on everyday life 6 months after hospital discharge. Included participants were discharged 6 months previously from inpatient care, and selected from a patient cohort. All participants had selfreported symptoms at a 3-month follow-up and were of working age. Individual interviews were conducted with 15 participants (10 men, 5 women) following an interview guide developed together with patient partners, who were contributing to the research process. The interviews were analysed using thematic analysis. The results of the analysis revealed that the recovery process was experienced as a rocky and uncertain road, often involving setbacks. A wide range of persistent, fluctuating or newly developed symptoms had negative impacts on many areas of daily life, with fatigue and lack of energy being especially challenging. Participants used a variety of strategies to manage everyday life and recover.